Clinical Trial Update: Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cotrimoxazole as a de-escalation therapy for ventilator-associated pneumonia in the ICU; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Cotrimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Ventilator Associated Pneumonia | Phase 3 | Status: RECRUITING